A new, updated account of poroid fungi in North America
Poroid fungi, commonly known as "polypores," are among the most frequently encountered fungi throughout the year because of their large ...
{"id":99443,"date":"2018-12-19T05:55:30","date_gmt":"2018-12-19T05:55:30","guid":{"rendered":"https:\/\/bioengineer.org\/high-cost-of-re-operation-after-breast-conserving-surgery\/"},"modified":"2018-12-19T05:55:30","modified_gmt":"2018-12-19T05:55:30","slug":"high-cost-of-re-operation-after-breast-conserving-surgery","status":"publish","type":"post","link":"https:\/\/bioengineer.org\/high-cost-of-re-operation-after-breast-conserving-surgery\/","title":{"rendered":"High cost of re-operation after breast-conserving surgery"},"content":{"rendered":"
\n
<\/p>\n
A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer.<\/p>\n
A new BJS (British Journal of Surgery)<\/em> analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings.<\/p>\n Using data from relevant published studies, the authors found the median hospital costs of women who needed re-operation were \u00a34,511, \u00a32,136 more than in women whose surgical margins were clear.<\/p>\n If these cost estimates are applied nationally, they provide compelling encouragement to seek interventions to minimize re-operation after BCS, which would reduce associated costs.\n<\/p>\n ###<\/p>\n<\/p><\/div>\n Media Contact<\/strong> A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer. A new BJS (British Journal of Surgery) analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings. Using data from relevant published studies, the […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"footnotes":""},"categories":[231],"tags":[315,293,334,317],"class_list":["post-99443","post","type-post","status-publish","format-standard","hentry","category-cancer-science-news","tag-breast-cancer","tag-medicine-health","tag-public-health","tag-surgery"],"_links":{"self":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/99443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/comments?post=99443"}],"version-history":[{"count":0,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/posts\/99443\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/media?parent=99443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/categories?post=99443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioengineer.org\/wp-json\/wp\/v2\/tags?post=99443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Josh Glickman
newsroom@wiley.com
http:\/\/dx.